Vanessa Wu

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents

Cheng Wang, Dong Ji, Jing Chen et al. · Clinical Gastroenterology and Hepatology · 2016 · 197 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Detection of Early Human Papillomavirus–Associated Cancers by Liquid Biopsy

Rama Rao Damerla, Nancy Y. Lee, Daoqui You et al. · JCO Precision Oncology · 2019 · 127 citations

Medicine, Oncology, Pathology +17

Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study

George Lau, Yves Benhamou, Guofeng Chen et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data

Guofeng Chen, Lai Wei, Jing Chen et al. · PLoS ONE · 2016 · 44 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

Dong Ji, Xiao-Xia Niu, Mingjie Zhang et al. · Metabolism Open · 2021 · 37 citations · Full text

Medicine, Oncology, Clinical Epidemiology +16